Cathie Wood's position in Beam Therapeutics is currently worth $186 Million. That's 1.48% of their equity portfolio (21st largest holding). The investor owns 9.37% of the outstanding Beam Therapeutics stock. The first Beam Therapeutics trade was made in Q4 2020. Since then Cathie Wood bought shares nine more times and sold shares on four occasions. The investor's estimated purchase price is $604 Million, resulting in a loss of 69%.